Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P20810: Variant p.Glu592Gly

Calpastatin
Gene: CAST
Feedback?
Variant information Variant position: help 592 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glutamate (E) to Glycine (G) at position 592 (E592G, p.Glu592Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page



Sequence information Variant position: help 592 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 708 The length of the canonical sequence.
Location on the sequence: help DKLSDSLGQRQPDPDENKPM E DKVKEKAKAEHRDKLGERDD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         DKLSDSLGQRQPDPDENKPMEDKVKEKAKAEHRDKLGERDD

Mouse                         DELSDSLGQRPPDPDENKPLDDKVKEKIKPEHSEKLGERDD

Rat                           DELSDSLGQRQPDPDENKPLDDKVKEKIKAEHSEKLGERDD

Pig                           DQLSDSLGQRQPDPDENKPIEDKVKEKAEAEHRDKLGERDD

Bovine                        DQLSDTLGQRQPDPDENKPVEDKVKEKAKAEHRDKLGERDD

Rabbit                        DKLSDSLGQRQPDPDENKPMEDKVKERAKKEHKDKLGERDD

Sheep                         DQLSDSLGQRQPDPDEHKPVEDKVKEKAKAEHRDKLGERDD

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 708 Calpastatin
Repeat 583 – 636 Inhibitory domain 4
Region 543 – 708 Disordered
Compositional bias 561 – 650 Basic and acidic residues
Modified residue 575 – 575 Phosphoserine
Modified residue 577 – 577 Phosphoserine



Literature citations
cDNA cloning of human calpastatin: sequence homology among human, pig, and rabbit calpastatins.
Asada K.; Ishino Y.; Shimada M.; Shimojo T.; Endo M.; Kimizuka F.; Kato I.; Maki M.; Hatanaka M.; Murachi T.;
J. Enzym. Inhib. 3:49-56(1989)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANTS SER-408 AND GLY-592;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.